Effects of fluvoxamine on morphine-induced inhibition of gastrointestinal transit, antinociception and hyperlocomotion in mice

Neuroscience Letters

Volumn 299, Issue 1-2, 2001, Pages 29-32

  Ise, Yuya ^a,b   Katayama, Shirou ^a   Hirano, Masaaki ^a   Aoki, Takeshi ^b   Narita, Minoru ^b   Suzuki, Tsutomu ^b  

^a NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

Antinociceptive effect; Fluvoxamine; Gastrointestinal transit; Locomotor activity; Morphine; Terminal stage of cancer

Indexed keywords

FLUVOXAMINE; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CANCER PATIENT; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; GASTROINTESTINAL TRANSIT; LIMBIC SYSTEM; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMALS; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FLUVOXAMINE; GASTROINTESTINAL TRANSIT; HYPERKINESIS; MICE; MORPHINE; NEOPLASMS; NOCICEPTORS; PAIN, INTRACTABLE; SEROTONIN UPTAKE INHIBITORS; TERMINAL CARE; TERMINALLY ILL;

EID: 0035895704     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01768-7     Document Type: Article

References (21)

1. Interactions between different antidepressants and morphine alter gastrointestinal transit in mice
2. Mediation of serotonin-induced analgesia by the 5-HT receptor in the pentobarbital anaesthetized mouse model
3. Efficacy and safety of mianserin in the treatment of depression of women with cancer
4. A comparison of paroxetine, imipramine and placebo in depressed out-patients
5. The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds
6. Electrocardiographic findings during extended clinical trials of fluvoxamine in depression: One years experience
7. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer
8. Effect of diabetics on the morphine-induced inhibition of gastrointestinal transit
9. Diagnosis of major depression in cancer patients according to four sets of criteria
10. Two types of receptors for 5-hydroxytryptamine on the cholinergic nerves of the guinea-pig myenteric plexus
11. Mental disorders in cancer patients: A study of 100 psychiatric referrals
12. The outcome of antidepressant use in the medically ill
13. Serum vasoconstrictor (serotonin)
14. The antinociceptive effect of fluvoxamine
15. Fluoxetine attenuates morphine-induced locomotion and blocks morphine-sensitization
16. Effects of agents increasing serotonin transmission on the increase of dopamine metabolism caused by morphine in the rat nucleus accumbens
17. 3-receptor agonist (±)-7-hydroxy-N,N-di-n-propyl-2-amino-tetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice
18. Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors
19. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features
20. Sensitization occurs to the locomotor effects of morphine and the specific μ opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens
21. As-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs